David E. Wazer, M.D. is Professor and Chairman of the Department of Radiation Oncology at Brown University. He is radiation oncologist-in-chief at Rhode Island Hospital, the Miriam Hospital, Newport Hospital, and Women and Infants Hospital. He serves as Director of the Lifespan Cancer Institute.
Dr. Wazer is an internationally recognized expert in the application of new technology in the field of radiation oncology. He has published more than 300 scientific articles, and has authored/edited several books including “Accelerated Partial Breast Irradiation”, "Short Course Breast Radiotherapy", and “Image-guided IMRT”. In addition, he is the Co-Editor of “Principles and Practice of Radiation Oncology”, the widely recognized premier textbook of radiation oncology. Dr. Wazer is Editor-in-Chief of the American Journal of Clinical Oncology and serves as associate editor of the journals Brachytherapy, Frontiers in Radiation Oncology, and Breast Diseases: a Yearbook Quarterly.
Dr. Wazer is board certified in therapeutic radiology by the American Board of Radiology. He earned his medical degree from the New York University School of Medicine. On completion of medical school, he performed a research fellowship in neuropharmacology at NYU. He obtained clinical training in internal medicine at Brown University and in radiation oncology at Tufts University. He has held a number of faculty and research positions at Tufts, Brown, and MIT. He has been a member of several national and international advisory committees related to the science and technology of radiation oncology.
Dr. Wazer’s current areas of clinical research include the study of the efficacy, toxicity, and cost/utility analysis of image-guided radiation therapy, proton beam radiotherapy, partial breast irradiation, and brachytherapy. He is actively involved in the development of clinical trials for cancers of the breast, skin, GI tract, and lung. He is also actively engaged in multiple initiatives to promote and advance oncology care in the developing world.
Dr. Wazer is a Fellow of the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), and the American College of Radiation Oncology (ACRO). He is a member of the Radiation Research Society, the American Society of Clinical Oncology, the American Radium Society, and the American Association for the Advancement of Science. He has served on the Board of Directors and as President of The American Brachytherapy Society and as a member of the Radiation Oncology Commission for the American College of Radiology
| Hepel JT, Yashar C, Leonard KL, Einck JP, Sha S, DiPetrillo T, Wiggins D, Graves TA, Edmonson D, Brown University Oncology Research Group., Wazer DE. "Five fraction accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy: Feasibility and acute toxicity." Brachytherapy, vol. 17, no. 5, 2018, pp. 825-830. |
| Brownlee, Zachary, Garg, Rashi, Listo, Matthew, Zavitsanos, Peter, Wazer, David E., Huber, Kathryn E. "Late complications of radiation therapy for breast cancer: evolution in techniques and risk over time." Gland Surgery, vol. 7, no. 4, 2018, pp. 371-378. |
| Foster B, Sindhu K, Hepel J, Wazer D, Graves T, Taneja C, Wiggins D, Leonard K. "Three-Dimensional Bioabsorbable Tissue Marker Placement is Associated with Decreased Tumor Bed Volume Among Patients Receiving Radiation Therapy for Breast Cancer." Practical radiation oncology, 2018. |
| Gorovets D, Ayala-Peacock D, Tybor DJ, Rava P, Ebner D, Cielo D, Norén G, Wazer DE, Chan M, Hepel JT. "Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain Metastases." International Journal of Radiation Oncology*Biology*Physics, vol. 97, no. 2, 2017, pp. 246-253. |
| Vicini F, Shah C, Tendulkar R, Wobb J, Arthur D, Khan A, Wazer D, Keisch M. "Accelerated partial breast irradiation: An update on published Level I evidence." Brachytherapy, vol. 15, no. 5, 2016, pp. 607-15. |
| Leonard, K.-L., Wazer, D. E. "Genomic Assays and Individualized Treatment of Ductal Carcinoma In Situ in the Era of Value-Based Cancer Care." Journal of Clinical Oncology, vol. 34, no. 33, 2016, pp. 3953-3955. |
| Wazer, David E. "Introduction: The Changing Spectrum of Breast Cancer." Seminars in Radiation Oncology, vol. 26, no. 1, 2016, pp. 1-2. |
| Shah, Chirag, Wobb, Jessica, Manyam, Bindu, Kundu, Neilendu, Arthur, Douglas, Wazer, David, Fernandez, Eduardo, Vicini, Frank. "Management of Ductal Carcinoma In Situ of the Breast." JAMA Oncology, vol. 2, no. 8, 2016, pp. 1083. |
| Vicini F, Shah C, Arthur D, Khan A, Wazer D, Keisch M. "Partial breast irradiation and the GEC-ESTRO trial." The Lancet, vol. 387, no. 10029, 2016, pp. 1717-8. |
| Shah C, Vicini F, Khan A, Arthur D, Wazer D. "Radiation Therapy and the Evolving Definition of Low Risk in Ductal Carcinoma in Situ." Journal of Clinical Oncology, vol. 34, no. 15, 2016, pp. 1823-4. |
| Shah, Chirag, Khan, Atif, Arthur, Douglas, Wazer, David, Mantz, Constantine, Verma, Vivek, Vicini, Frank. "Regional Nodal Irradiation." American Journal of Clinical Oncology, vol. 39, no. 1, 2016, pp. 90-91. |
| Hepel, Jaroslaw T., Leonard, Kara Lynne, Safran, Howard, Ng, Thomas, Taber, Angela, Khurshid, Humera, Birnbaum, Ariel, Wazer, David E., DiPetrillo, Thomas. "Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study." International Journal of Radiation Oncology*Biology*Physics, vol. 96, no. 5, 2016, pp. 1021-1027. |
| Schuster J, Chipko C, Kasper M, Sha S, Ciuba D, Petrikas J, Kuruvilla A, Sandrapaty R, Quiet C, Anderson C, Benda R, Wazer D, Hepel J, Arthur D. "Updated feasibility and reproducibility results of multi-institutional study of noninvasive breast tumor bed boost." Brachytherapy, vol. 15, no. 6, 2016, pp. 804-811. |
| Hepel, Jaroslaw, Wazer, David E. "A Flawed Study Should Not Define a New Standard of Care." International Journal of Radiation Oncology*Biology*Physics, vol. 91, no. 2, 2015, pp. 255-257. |
| Petereit, D. G., Frank, S. J., Viswanathan, A. N., Erickson, B., Eifel, P., Nguyen, P. L., Wazer, D. E. "Brachytherapy: Where Has It Gone?." Journal of Clinical Oncology, vol. 33, no. 9, 2015, pp. 980-982. |
| Wazer, David E., Hepel, Jaroslaw T., Riker, Adam I., Harness, Jay K., Chung, Caroline, Khan, Atif J., Offersen, Birgitte Vrou, Poortmans, Philip, Taghian, Alphonse. "In Regard to Vaidya et al." International Journal of Radiation Oncology*Biology*Physics, vol. 92, no. 5, 2015, pp. 952-953. |
| Wazer, David E. "Tribute to Dr. Cynthia Kretschmar, MD." American Journal of Clinical Oncology, vol. 38, no. 4, 2015, pp. 337. |
| Silverstein, Melvin J., Fastner, Gerd, Maluta, Sergio, Reitsamer, Roland, Goer, Donald A., Vicini, Frank, Wazer, David. "Intraoperative Radiation Therapy: A Critical Analysis of the ELIOT and TARGIT Trials. Part 1—ELIOT." Annals of Surgical Oncology, vol. 21, no. 12, 2014, pp. 3787-3792. |
| Silverstein, Melvin J., Fastner, Gerd, Maluta, Sergio, Reitsamer, Roland, Goer, Donald A., Vicini, Frank, Wazer, David. "Intraoperative Radiation Therapy: A Critical Analysis of the ELIOT and TARGIT Trials. Part 2—TARGIT." Annals of Surgical Oncology, vol. 21, no. 12, 2014, pp. 3793-3799. |
| Joye RP, Williams LB, Chan MD, Witkin AJ, Schirmer CM, Mignano JE, Wazer DE, Yao KC, Wu JK, Duker JS. "Local control and results of Leksell Gamma Knife therapy for the treatment of uveal melanoma." Ophthalmic surgery, lasers & imaging retina, vol. 45, no. 2, 2014, pp. 125-31. |
| Logan JK, Huber KE, Dipetrillo TA, Wazer DE, Leonard KL. "Patterns of care of radiation therapy in patients with stage IV rectal cancer: a Surveillance, Epidemiology, and End Results analysis of patients from 2004 to 2009." Cancer, vol. 120, no. 5, 2014, pp. 731-7. |
| Harness JK, Silverstein MJ, Wazer DE, Riker AI. "Radiotherapy for breast cancer, the TARGIT-A trial." The Lancet, vol. 383, no. 9930, 2014, pp. 1718-9. |
| Hepel JT, Hiatt JR, Sha S, Leonard KL, Graves TA, Wiggins DL, Mastras D, Pittier A, Brown University Oncology Research Group, Wazer DE. "The rationale, technique, and feasibility of partial breast irradiation using noninvasive image-guided breast brachytherapy." Brachytherapy, vol. 13, no. 5, 2014, pp. 493-501. |
| Leonard KL, Hepel JT, Styczynski JR, Hiatt JR, Dipetrillo TA, Wazer DE. "Breast boost using noninvasive image-guided breast brachytherapy vs. external beam: a 2:1 matched-pair analysis." Clinical Breast Cancer, vol. 13, no. 6, 2013, pp. 455-9. |
| Stewart AJ, Hepel JT, O'Farrell DA, Devlin PM, Price LL, Dale RG, Wazer DE. "Equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, vol. 108, no. 2, 2013, pp. 232-5. |
| Wilkinson JB, Beitsch PD, Shah C, Arthur D, Haffty BG, Wazer DE, Keisch M, Shaitelman SF, Lyden M, Chen PY, Vicini FA. "Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite Registry Trial Data." International Journal of Radiation Oncology*Biology*Physics, vol. 85, no. 5, 2013, pp. 1179-85. |
| Hepel JT, Wazer DE. "Should a woman age 70 to 80 years receive radiation after breast-conserving surgery?." Journal of Clinical Oncology, vol. 31, no. 19, 2013, pp. 2377-81. |
| Rava P, Leonard K, Sioshansi S, Curran B, Wazer DE, Cosgrove GR, Norén G, Hepel JT. "Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery." Journal of Neurosurgery, vol. 119, no. 2, 2013, pp. 457-62. |
| Shah C, Vicini F, Wazer DE, Arthur D, Patel RR. "The American Brachytherapy Society consensus statement for accelerated partial breast irradiation." Brachytherapy, vol. 12, no. 4, 2013, pp. 267-77. |
| Leonard KL, Hepel JT, Hiatt JR, Dipetrillo TA, Price LL, Wazer DE. "The effect of dose-volume parameters and interfraction interval on cosmetic outcome and toxicity after 3-dimensional conformal accelerated partial breast irradiation." International Journal of Radiation Oncology*Biology*Physics, vol. 85, no. 3, 2013, pp. 623-9. |
| Dvorak T, Fitzek MM, Wazer DE. "Utilization of proton therapy: evidence-based, market-driven, or something in-between?." American Journal of Clinical Oncology, vol. 36, no. 2, 2013, pp. 192-6. |
| Cuttino LW, Khan A, Wazer DE, Arthur DW, Vicini FA. "When retrospective comparative effectiveness research hinders science and patient-centered care." Journal of Clinical Oncology, vol. 31, no. 17, 2013, pp. 2226-7. |
| Hepel JT, Wazer DE. "A comparison of brachytherapy techniques for partial breast irradiation." Brachytherapy, vol. 11, no. 3, 2012, pp. 163-75. |
| Rava P, Dvorak T, Markelewicz RJ Jr, Hiatt JR, Sternick ES, MacAusland SG, Huber K, Wazer DE, Hepel JT. "A comparison of the biological effective dose of 50-kV electronic brachytherapy with (192)Ir high-dose-rate brachytherapy for vaginal cuff irradiation." Brachytherapy, vol. 11, no. 5, 2012, pp. 402-7. |
| Hamid S, Rocchio K, Arthur D, Vera R, Sha S, Jolly M, Cavanaugh S, Wooten E, Benda R, Greenfield B, Prestidge B, Ackerman S, Kuske R, Quiet C, Snyder M, Wazer DE. "A multi-institutional study of feasibility, implementation, and early clinical results with noninvasive breast brachytherapy for tumor bed boost." International Journal of Radiation Oncology*Biology*Physics, vol. 83, no. 5, 2012, pp. 1374-80. |
| Cuttino LW, White JR, Rabinovitch R, Gewirtz DA, Anscher MS, Wazer DE, Vicini FA, Julian TB, Arthur DW. "Accelerated partial-breast irradiation: trial by media or by science?." International Journal of Radiation Oncology*Biology*Physics, vol. 83, no. 4, 2012, pp. 1075-7. |
| Chaulagain CP, Ng J, Wazer D, Saif MW. "Adjuvant therapy of pancreatic cancer." JOP : Journal of the pancreas, vol. 13, no. 4, 2012, pp. 349-53. |
| Leonard KL, Solomon D, Hepel JT, Hiatt JR, Wazer DE, DiPetrillo TA. "Axillary lymph node dose with tangential whole breast radiation in the prone versus supine position: a dosimetric study." Radiation oncology (London, England), vol. 7, 2012, pp. 72. |
| Wazer DE. "Measuring the value of radiotherapy in older women with breast cancer." Journal of Clinical Oncology, vol. 30, no. 23, 2012, pp. 2809-11. |
| Ahmed WB, Ng J, Wazer DE, Saif MW. "New tools and novel approaches in treating locally advanced pancreatic adenocarcinoma." JOP : Journal of the pancreas, vol. 13, no. 4, 2012, pp. 354-7. |
| Evans SB, Sioshansi S, Moran MS, Hiatt J, Price LL, Wazer DE. "Prevalence of poor cardiac anatomy in carcinoma of the breast treated with whole-breast radiotherapy: reconciling modern cardiac dosimetry with cardiac mortality data." American Journal of Clinical Oncology, vol. 35, no. 6, 2012, pp. 587-92. |
| Sioshansi S, Ehdaivand S, Cramer C, Lomme MM, Price LL, Wazer DE. "Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy." Cancer, vol. 118, no. 16, 2012, pp. 3893-8. |
| Leonard KL, DiPetrillo TA, Munro JJ, Wazer DE. "A novel ytterbium-169 brachytherapy source and delivery system for use in conjunction with minimally invasive wedge resection of early-stage lung cancer." Brachytherapy, vol. 10, no. 2, 2011, pp. 163-9. |
| Sioshansi S, Rivard MJ, Hiatt JR, Hurley AA, Lee Y, Wazer DE. "Dose modeling of noninvasive image-guided breast brachytherapy in comparison to electron beam boost and three-dimensional conformal accelerated partial breast irradiation." International Journal of Radiation Oncology*Biology*Physics, vol. 80, no. 2, 2011, pp. 410-6. |
| Cohen DM, Hiatt JR, O'Connor B, Curran B, Sternick ES, Wazer DE. "Exploring the potential of mixed-source brachytherapy for the treatment of cervical cancer using high-dose rate 192Ir and/or 50 kV electronic sources." Brachytherapy, vol. 10, no. 2, 2011, pp. 141-6. |
| Vicini F, Arthur D, Wazer D, Chen P, Mitchell C, Wallace M, Kestin L, Ye H. "Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation." International Journal of Radiation Oncology*Biology*Physics, vol. 79, no. 4, 2011, pp. 977-84. |
| Sioshansi S, Huber KE, Wazer DE. "The implications of breast cancer molecular phenotype for radiation oncology." Frontiers in Oncology, vol. 1, 2011, pp. 12. |
| Dragun AE, Harper JL, Olyejar SE, Zunzunegui RG, Wazer DE. "The use of adjuvant high-dose-rate breast brachytherapy in patients with collagen vascular disease: a collaborative experience." Brachytherapy, vol. 10, no. 2, 2011, pp. 121-7. |
| Dvorak T, Wazer DE. "Evaluation of potential proton therapy utilization in a market-based environment." Journal of the American College of Radiology : JACR, vol. 7, no. 7, 2010, pp. 522-8. |
| Mehta VK, Algan O, Griem KL, Dickler A, Haile K, Wazer DE, Stevens RE, Chadha M, Kurtzman S, Modin SD, Dowlatshahi K, Elliott KW, Rusch TW. "Experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation." American Journal of Clinical Oncology, vol. 33, no. 4, 2010, pp. 327-35. |
| Hepel JT, Hiatt JR, Cardarelli GA, Wazer DE. "Modeling study for optimization of skin dose for partial breast irradiation using Xoft Axxent electronic brachytherapy applicator." Brachytherapy, vol. 9, no. 1, 2010, pp. 81-5. |
| Sanghani M, Truong PT, Raad RA, Niemierko A, Lesperance M, Olivotto IA, Wazer DE, Taghian AG. "Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy." Journal of Clinical Oncology, vol. 28, no. 5, 2010, pp. 718-22. |
| Dickler A, Patel RR, Wazer D. "Breast brachytherapy devices." Expert review of medical devices, vol. 6, no. 3, 2009, pp. 325-33. |
| Huber KE, Carey LA, Wazer DE. "Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy." Seminars in radiation oncology, vol. 19, no. 4, 2009, pp. 204-10. |
| Rivard MJ, Melhus CS, Wazer DE, Bricault RJ Jr. "Dosimetric characterization of round HDR 192Ir accuboost applicators for breast brachytherapy." Medical physics, vol. 36, no. 11, 2009, pp. 5027-32. |
| Hepel JT, Evans SB, Hiatt JR, Price LL, DiPetrillo T, Wazer DE, MacAusland SG. "Planning the breast boost: comparison of three techniques and evolution of tumor bed during treatment." International Journal of Radiation Oncology*Biology*Physics, vol. 74, no. 2, 2009, pp. 458-63. |
| Wazer DE. "Point: Brachytherapy for accelerated partial breast irradiation." Brachytherapy, vol. 8, no. 2, 2009, pp. 181-3; discussion 189. |
| Hepel JT, Tokita M, MacAusland SG, Evans SB, Hiatt JR, Price LL, DiPetrillo T, Wazer DE. "Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation." International Journal of Radiation Oncology*Biology*Physics, vol. 75, no. 5, 2009, pp. 1290-6. |
| Hiatt J, Cardarelli G, Hepel J, Wazer D, Sternick E. "A commissioning procedure for breast intracavitary electronic brachytherapy systems." Journal of applied clinical medical physics / American College of Medical Physics, vol. 9, no. 3, 2008, pp. 2775. |
| Dickler A, Kirk MC, Coon A, Bernard D, Zusag T, Rotmensch J, Wazer DE. "A dosimetric comparison of Xoft Axxent Electronic Brachytherapy and iridium-192 high-dose-rate brachytherapy in the treatment of endometrial cancer." Brachytherapy, vol. 7, no. 4, 2008, pp. 351-4. |
| Hepel JT, MacAusland SG, Long JP, Wazer DE, DiPetrillo T. "Intensity-modulated radiotherapy of the prostate after cryotherapy: initial experience." Urology, vol. 72, no. 6, 2008, pp. 1310-4; discussion 1314. |
| Evans SB, Gass J, Wazer DE. "Management of the axilla after the finding of a positive sentinel lymph node: a proposal for an evidence-based risk-adapted algorithm." American Journal of Clinical Oncology, vol. 31, no. 3, 2008, pp. 293-9. |
| Cuttino LW, Keisch M, Jenrette JM, Dragun AE, Prestidge BR, Quiet CA, Vicini FA, Rescigno J, Wazer DE, Kaufman SA, Ramakrishnan VR, Patel R, Arthur DW. "Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results." International Journal of Radiation Oncology*Biology*Physics, vol. 71, no. 1, 2008, pp. 107-14. |
| Paulson KE, Rieger-Christ K, McDevitt MA, Kuperwasser C, Kim J, Unanue VE, Zhang X, Hu M, Ruthazer R, Berasi SP, Huang CY, Giri D, Kaufman S, Dugan JM, Blum J, Netto G, Wazer DE, Summerhayes IC, Yee AS. "Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer." Cancer Research, vol. 67, no. 13, 2007, pp. 6136-45. |
| MacAusland SG, Hepel JT, Chong FK, Galper SL, Gass JS, Ruthazer R, Wazer DE. "An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ." Cancer, vol. 110, no. 12, 2007, pp. 2648-53. |
| Kaufman SA, DiPetrillo TA, Price LL, Midle JB, Wazer DE. "Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer." Brachytherapy, vol. 6, no. 4, 2007, pp. 286-92. |
| Sanghani M, Wazer DE. "Patient selection for NSABP B-39/RTOG 0413: have we posed the right questions in the right way?." Brachytherapy, vol. 6, no. 2, 2007, pp. 119-22. |
| Sanghani M, Balk E, Cady B, Wazer D. "Predicting the risk of local recurrence in patients with breast cancer: an approach to a new computer-based predictive tool." American Journal of Clinical Oncology, vol. 30, no. 5, 2007, pp. 473-80. |
| Zhao Y, Katzman RB, Delmolino LM, Bhat I, Zhang Y, Gurumurthy CB, Germaniuk-Kurowska A, Reddi HV, Solomon A, Zeng MS, Kung A, Ma H, Gao Q, Dimri G, Stanculescu A, Miele L, Wu L, Griffin JD, Wazer DE, Band H, Band V. "The notch regulator MAML1 interacts with p53 and functions as a coactivator." Journal of Biological Chemistry, vol. 282, no. 16, 2007, pp. 11969-81. |
| Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW. "Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy." International Journal of Radiation Oncology*Biology*Physics, vol. 64, no. 2, 2006, pp. 489-95. |
| Kaufman SA, DiPetrillo TA, Wazer DE. "Accelerated partial breast irradiation: current modalities and investigations." Medicine and health, Rhode Island, vol. 89, no. 2, 2006, pp. 70-3. |
| Hiatt JR, Evans SB, Price LL, Cardarelli GA, Dipetrillo TA, Wazer DE. "Dose-modeling study to compare external beam techniques from protocol NSABP B-39/RTOG 0413 for patients with highly unfavorable cardiac anatomy." International Journal of Radiation Oncology*Biology*Physics, vol. 65, no. 5, 2006, pp. 1368-74. |
| Li J, Zou C, Bai Y, Wazer DE, Band V, Gao Q. "DSS1 is required for the stability of BRCA2." Oncogene, vol. 25, no. 8, 2006, pp. 1186-94. |
| Zhang Y, Bhat I, Zeng M, Jayal G, Wazer DE, Band H, Band V. "Human kallikrein 10, a predictive marker for breast cancer." Biological Chemistry, vol. 387, no. 6, 2006, pp. 715-21. |
| Evans SB, Kaufman SA, Price LL, Cardarelli G, Dipetrillo TA, Wazer DE. "Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: incidence, pathologic anatomy, and contributing factors." International Journal of Radiation Oncology*Biology*Physics, vol. 65, no. 2, 2006, pp. 333-9. |
| Hernandez S, Evans SB, Wazer DE. "Severe acute toxicity from whole breast radiotherapy in the setting of collagen vascular disease." American Journal of Clinical Oncology, vol. 29, no. 6, 2006, pp. 647-8. |
| Kim J, Zhang X, Rieger-Christ KM, Summerhayes IC, Wazer DE, Paulson KE, Yee AS. "Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1." Journal of Biological Chemistry, vol. 281, no. 16, 2006, pp. 10865-75. |
| Zhang X, Kim J, Ruthazer R, McDevitt MA, Wazer DE, Paulson KE, Yee AS. "The HBP1 transcriptional repressor participates in RAS-induced premature senescence." Molecular and Cellular Biology, vol. 26, no. 22, 2006, pp. 8252-66. |
| Zeng M, Zhang Y, Bhat I, Wazer DE, Band H, Band V. "The human kallikrein 10 promoter contains a functional retinoid response element." Biological Chemistry, vol. 387, no. 6, 2006, pp. 741-7. |
| Arthur DW, Cuttino LW, Neuschatz AC, Koo DT, Morris MM, Bear HD, Kaplan BJ, Dawson K, Wazer DE. "Tumor bed boost omission after negative re-excision in breast-conservation treatment." Annals of Surgical Oncology, vol. 13, no. 6, 2006, pp. 794-801. |
| Rivard MJ, Melhus CS, Zinkin HD, Stapleford LJ, Evans KE, Wazer DE, Odlozilíková A. "A radiobiological model for the relative biological effectiveness of high-dose-rate 252Cf brachytherapy." Radiation Research, vol. 164, no. 3, 2005, pp. 319-23. |
| Wazer DE. "A remembrance of Rupert K. A. Schmidt-Ullrich, M.D." International Journal of Radiation Oncology*Biology*Physics, vol. 62, no. 1, 2005, pp. 1-2. |
| Meng G, Zhao Y, Nag A, Zeng M, Dimri G, Gao Q, Wazer DE, Kumar R, Band H, Band V. "BRCA2 suppresses cell proliferation via stabilizing MAGE-D1." Journal of Biological Chemistry, vol. 279, no. 11, 2005, pp. 4747-53. |
| Zou C, Li J, Bai Y, Gunning WT, Wazer DE, Band V, Gao Q. "Centrobin: a novel daughter centriole-associated protein that is required for centriole duplication." The Journal of cell biology, vol. 171, no. 3, 2005, pp. 437-45. |
| Kaufman SA, Dipetrillo TA, Ruthazer R, Wazer DE. "MammoSite excision volume as a predictor for residual disease." Cancer, vol. 104, no. 5, 2005, pp. 906-12. |
| Shah NM, Wazer DE. "The MammoSite balloon brachytherapy catheter for accelerated partial breast irradiation." Seminars in radiation oncology, vol. 15, no. 2, 2005, pp. 100-7. |
| Rivard MJ, Kirk BL, Stapleford LJ, Wazer DE. "A comparison of the expected costs of high dose rate brachytherapy using 252Cf versus 192Ir." Applied Radiation and Isotopes, vol. 61, no. 6, 2004, pp. 1211-6. |
| Zinkin HD, Rivard MJ, Mignano JE, Wazer DE. "Analysis of dose conformity and normal-tissue sparing using two different IMRT prescription methodologies for irregularly shaped CNS lesions irradiated with the Beak and 1-cm MIMiC collimators." International Journal of Radiation Oncology*Biology*Physics, vol. 59, no. 1, 2004, pp. 285-92. |
| Shah NM, Tenenholz T, Arthur D, DiPetrillo T, Bornstein B, Cardarelli G, Zheng Z, Rivard MJ, Kaufman S, Wazer DE. "MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis." Cancer, vol. 101, no. 4, 2004, pp. 727-34. |
| Arthur DW, Vicini FA, Kuske RR, Wazer DE, Nag S, American Brachytherapy Society. "Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society." Brachytherapy, vol. 2, no. 2, 2003, pp. 124-30. |
| Marshall JK, Griffith KA, Haffty BG, Solin LJ, Vicini FA, McCormick B, Wazer DE, Recht A, Pierce LJ. "Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results." Cancer, vol. 97, no. 9, 2003, pp. 2142-9. |
| Tsai JS, Rivard MJ, Engler MJ, Mignano JE, Wazer DE, Shucart WA. "Determination of the 4 mm Gamma Knife helmet relative output factor using a variety of detectors." Medical physics, vol. 30, no. 5, 2003, pp. 986-92. |
| Zhou P, Fernandes N, Dodge IL, Reddi AL, Rao N, Safran H, DiPetrillo TA, Wazer DE, Band V, Band H. "ErbB2 degradation mediated by the co-chaperone protein CHIP." Journal of Biological Chemistry, vol. 278, no. 16, 2003, pp. 13829-37. |
| Vicini FA, Arthur DW, Wazer DE. "Inconsistency, perspective, double talk, and false virtue." Brachytherapy, vol. 2, no. 2, 2003, pp. 121-3. |
| Neuschatz AC, DiPetrillo T, Safaii H, Price LL, Schmidt-Ullrich RK, Wazer DE. "Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy." Cancer, vol. 97, no. 1, 2003, pp. 30-9. |
| Yunes MJ, Neuschatz AC, Bornstein LE, Naber SP, Band V, Wazer DE. "Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery." International Journal of Radiation Oncology*Biology*Physics, vol. 56, no. 3, 2003, pp. 653-7. |
| Singh L, Gao Q, Kumar A, Gotoh T, Wazer DE, Band H, Feig LA, Band V. "The high-risk human papillomavirus type 16 E6 counters the GAP function of E6TP1 toward small Rap G proteins." Journal of Virology, vol. 77, no. 2, 2003, pp. 1614-20. |
| Arthur DW, Vicini FA, Kuske RR, Wazer DE, Nag S, American Brachytherapy Society. "Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society." Brachytherapy, vol. 1, no. 4, 2002, pp. 184-90. |
| Chung MA, Wazer D, Cady B. "Contemporary management of breast cancer." Obstetrics and gynecology clinics of North America, vol. 29, no. 1, 2002, pp. 173-88. |
| Zeng M, Kumar A, Meng G, Gao Q, Dimri G, Wazer D, Band H, Band V. "Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator." Journal of Biological Chemistry, vol. 277, no. 47, 2002, pp. 45611-8. |
| Gao Q, Kumar A, Singh L, Huibregtse JM, Beaudenon S, Srinivasan S, Wazer DE, Band H, Band V. "Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase." Cancer Research, vol. 62, no. 11, 2002, pp. 3315-21. |
| Kumar A, Zhao Y, Meng G, Zeng M, Srinivasan S, Delmolino LM, Gao Q, Dimri G, Weber GF, Wazer DE, Band H, Band V. "Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3." Molecular and Cellular Biology, vol. 22, no. 16, 2002, pp. 5801-12. |
| Morr J, DiPetrillo T, Tsai JS, Engler M, Wazer DE. "Implementation and utility of a daily ultrasound-based localization system with intensity-modulated radiotherapy for prostate cancer." International Journal of Radiation Oncology*Biology*Physics, vol. 53, no. 5, 2002, pp. 1124-9. |
| Vicini FA, Arthur DW, Wazer DE. "Inconsistency, perspective, double talk, and false virtue." Brachytherapy, vol. 1, no. 4, 2002, pp. 181-3. |
| Buchholz TA, Wazer DE. "Molecular biology and genetics of breast cancer development: a clinical perspective." Seminars in radiation oncology, vol. 12, no. 4, 2002, pp. 285-95. |
| Wazer DE, Berle L, Graham R, Chung M, Rothschild J, Graves T, Cady B, Ulin K, Ruthazer R, DiPetrillo TA. "Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer." International Journal of Radiation Oncology*Biology*Physics, vol. 53, no. 4, 2002, pp. 889-97. |
| Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, Van Lohuizen M, Campisi J, Wazer DE, Band V. "The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells." Cancer Research, vol. 62, no. 16, 2002, pp. 4736-45. |
| Neuschatz AC, DiPetrillo T, Steinhoff M, Safaii H, Yunes M, Landa M, Chung M, Cady B, Wazer DE. "The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast." Cancer, vol. 94, no. 7, 2002, pp. 1917-24. |
| Chung MA, DiPetrillo T, Hernandez S, Masko G, Wazer D, Cady B. "Treatment of the axilla by tangential breast radiotherapy in women with invasive breast cancer." The American Journal of Surgery, vol. 184, no. 5, 2002, pp. 401-2. |
| Dhar S, Bhargava R, Yunes M, Li B, Goyal J, Naber SP, Wazer DE, Band V. "Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer." Clin Cancer Res , vol. 7, no. 11, 2001, pp. 3393-8. |
| Wazer DE, Lowther D, Boyle T, Ulin K, Neuschatz A, Ruthazer R, DiPetrillo TA. "Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer." International Journal of Radiation Oncology*Biology*Physics, vol. 50, no. 1, 2001, pp. 107-11. |
| Mignano JE, Engler MJ, Tsai JS, Wazer DE. "Comparison of radiobiologic modeling for one- and two-isocenter dose distributions applied to ellipsoidal radiosurgery targets." International Journal of Radiation Oncology*Biology*Physics, vol. 49, no. 3, 2001, pp. 833-7. |
| Li B, Goyal J, Dhar S, Dimri G, Evron E, Sukumar S, Wazer DE, Band V. "CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression." Cancer Research, vol. 61, no. 21, 2001, pp. 8014-21. |
| Gao Q, Singh L, Kumar A, Srinivasan S, Wazer DE, Band V. "Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells." Journal of Virology, vol. 75, no. 9, 2001, pp. 4459-66. |
| Neuschatz AC, DiPetrillo T, Safaii H, Lowther D, Landa M, Wazer DE. "Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast." International Journal of Cancer, vol. 96 Suppl, 2001, pp. 97-104. |
| Ratsch SB, Gao Q, Srinivasan S, Wazer DE, Band V. "Multiple genetic changes are required for efficient immortalization of different subtypes of normal human mammary epithelial cells." Radiation Research, vol. 155, no. 1 Pt 2, 2001, pp. 143-150. |
| Wazer DE. "Contemporary issues in the use of radiation therapy for early invasive breast cancer." Surgical oncology clinics of North America, vol. 9, no. 3, 2000, pp. 585-601, x. |
| King CR, DiPetrillo TA, Wazer DE. "Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models." International Journal of Radiation Oncology*Biology*Physics, vol. 46, no. 1, 2000, pp. 165-72. |
| Gao Q, Kumar A, Srinivasan S, Singh L, Mukai H, Ono Y, Wazer DE, Band V. "PKN binds and phosphorylates human papillomavirus E6 oncoprotein." Journal of Biological Chemistry, vol. 275, no. 20, 2000, pp. 14824-30. |
| Tsai JS, Engler MJ, Ling MN, Wu JK, Kramer B, Dipetrillo T, Wazer DE. "A non-invasive immobilization system and related quality assurance for dynamic intensity modulated radiation therapy of intracranial and head and neck disease." International Journal of Radiation Oncology*Biology*Physics, vol. 43, no. 2, 1999, pp. 455-67. |
| Arthur DW, Schmidt-Ullrich RK, Friedman RB, Wazer DE, Kachnic LA, Amir C, Bear HD, Hackney MH, Smith TJ, Lawrence W Jr. "Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation." International Journal of Radiation Oncology*Biology*Physics, vol. 44, no. 2, 1999, pp. 289-96. |
| Kramer BA, Arthur DW, Ulin K, Schmidt-Ullrich RK, Zwicker RD, Wazer DE. "Cosmetic outcome in patients receiving an interstitial implant as part of breast-conservation therapy." Radiology, vol. 213, no. 1, 1999, pp. 61-6. |
| Wazer DE, Jabro G, Ruthazer R, Schmid C, Safaii H, Schmidt-Ullrich RK. "Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation." Radiation oncology investigations, vol. 7, no. 2, 1999, pp. 111-7. |
| Graham RA, Hackford AW, Wazer DE. "Local excision of rectal carcinoma: a safe alternative for more advanced tumors?." Journal of surgical oncology, vol. 70, no. 4, 1999, pp. 235-8. |
| Wazer DE, Band V. "Molecular and anatomic considerations in the pathogenesis of breast cancer." Radiation oncology investigations, vol. 7, no. 1, 1999, pp. 1-12. |
| Jabro G, Koc Y, Boyle T, Schenkein DP, Ravalese J, Wazer D, Miller KB. "Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol. 5, no. 3, 1999, pp. 173-9. |
| Gao Q, Srinivasan S, Boyer SN, Wazer DE, Band V. "The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation." Molecular and Cellular Biology, vol. 19, no. 1, 1999, pp. 733-44. |
| Jabro G, Wazer DE, Ruthazer R, Lum R, Sklar N, Goldman D, Enegess D, Erban J. "The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or = 10 positive axillary nodes." International Journal of Radiation Oncology*Biology*Physics, vol. 44, no. 2, 1999, pp. 273-80. |
| Wazer DE, Schmidt-Ullrich RK, Ruthazer R, DiPetrillo T, Boyle T, Kanski J, Safaii H. "The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor." International Journal of Radiation Oncology*Biology*Physics, vol. 45, no. 4, 1999, pp. 885-91. |
| Kramer BA, Wazer DE, Engler MJ, Tsai JS, Ling MN. "Dosimetric comparison of stereotactic radiosurgery to intensity modulated radiotherapy." Radiation oncology investigations, vol. 6, no. 1, 1998, pp. 18-25. |
| Tsai JS, Wazer DE, Ling MN, Wu JK, Fagundes M, DiPetrillo T, Kramer B, Koistinen M, Engler MJ. "Dosimetric verification of the dynamic intensity-modulated radiation therapy of 92 patients." International Journal of Radiation Oncology*Biology*Physics, vol. 40, no. 5, 1998, pp. 1213-30. |
| Wazer DE, Schmidt-Ullrich RK, Ruthazer R, Schmid CH, Graham R, Safaii H, Rothschild J, McGrath J, Erban JK. "Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed." International Journal of Radiation Oncology*Biology*Physics, vol. 40, no. 4, 1998, pp. 851-8. |
| Goyal J, Smith KM, Cowan JM, Wazer DE, Lee SW, Band V. "The role for NES1 serine protease as a novel tumor suppressor." Cancer Research, vol. 58, no. 21, 1998, pp. 4782-6. |
| Ulin K, Bornstein LE, Ling MN, Saris S, Wu JK, Curran BH, Wazer DE. "A technique for accurate planning of stereotactic brain implants prior to head ring fixation." International Journal of Radiation Oncology*Biology*Physics, vol. 39, no. 3, 1997, pp. 757-67. |
| Cao Y, Gao Q, Wazer DE, Band V. "Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells." Cancer Research, vol. 57, no. 24, 1997, pp. 5584-9. |
| Wazer DE, Kramer B, Schmid C, Ruthazer R, Ulin K, Schmidt-Ullrich R. "Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy." International Journal of Radiation Oncology*Biology*Physics, vol. 39, no. 2, 1997, pp. 381-93. |
| Kirkwood JM, Wazer D, Rosenstein M. "Interferon adjuvant therapy of melanoma." Cancer, vol. 79, no. 9, 1997, pp. 1843-6. |
| Vora SA, Wazer DE, Homer MJ. "Management of microcalcifications that develop at the lumpectomy site after breast-conserving therapy." Radiology, vol. 203, no. 3, 1997, pp. 667-71. |
| Rogers GS, Voseburg E, Wazer DE. "New approaches to treating advanced melanoma: adjuvant treatment of high-risk primary melanoma and boron neutron capture therapy." Seminars in cutaneous medicine and surgery, vol. 16, no. 2, 1997, pp. 165-73. |
| Gieger M, Wu JK, Ling MN, Wazer D, Tsai JS, Engler MJ. "Response of intracranial melanoma metastases to stereotactic radiosurgery." Radiation oncology investigations, vol. 5, no. 2, 1997, pp. 72-80. |
| Pierce LJ, Haffty BG, Solin LJ, McCormick B, Vicini FA, Wazer DE, Recht A, Strawderman M, Lichter AS. "The conservative management of Paget's disease of the breast with radiotherapy." Cancer, vol. 80, no. 6, 1997, pp. 1065-72. |
| Wazer DE, Morr J, Erban JK, Schmid CH, Ruthazer R, Schmidt-Ullrich RK. "The effects of postradiation treatment with tamoxifen on local control and cosmetic outcome in the conservatively treated breast." Cancer, vol. 80, no. 4, 1997, pp. 732-40. |
| Wazer DE, Schmidt-Ullrich RK, Schmid CH, Ruthazer R, Kramer B, Safaii H, Graham R. "The value of breast lumpectomy margin assessment as a predictor of residual tumor burden." International Journal of Radiation Oncology*Biology*Physics, vol. 38, no. 2, 1997, pp. 291-9. |
| Wazer DE, Gage I, Homer MJ, Krosnick SH, Schmid C. "Age-related differences in patients with nonpalpable breast carcinomas." Cancer, vol. 78, no. 7, 1996, pp. 1432-7. |
| Boyer SN, Wazer DE, Band V. "E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway." Cancer Research, vol. 56, no. 20, 1996, pp. 4620-4. |
| Liu XL, Wazer DE, Watanabe K, Band V. "Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression." Cancer Research, vol. 56, no. 14, 1996, pp. 3371-9. |
| Gao Q, Hauser SH, Liu XL, Wazer DE, Madoc-Jones H, Band V. "Mutant p53-induced immortalization of primary human mammary epithelial cells." Cancer Research, vol. 56, no. 13, 1996, pp. 3129-33. |
| Wazer DE, Liu XL, Chu Q, Gao Q, Band V. "Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7." Proceedings of the National Academy of Sciences, vol. 92, no. 9, 1995, pp. 3687-91. |
| Johnson CR, Khandelwal SR, Schmidt-Ullrich RK, Ravalese J 3rd, Wazer DE. "The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation." International Journal of Radiation Oncology*Biology*Physics, vol. 32, no. 3, 1995, pp. 635-41. |
| Wazer DE, Erban JK, Robert NJ, Smith TJ, Marchant DJ, Schmid C, DiPetrillo T, Schmidt-Ullrich R. "Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection." Cancer, vol. 74, no. 3, 1994, pp. 878-83. |
| Schmidt-Ullrich RK, Johnson CR, Khandelwal S, Wazer DE. "Concomitant boost-accelerated, superfractionated irradiation for the treatment of advanced carcinomas of the oral cavity and oropharynx." Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, vol. 134, 1994, pp. 69-79. |
| Engler MJ, Curran BH, Tsai JS, Sternick ES, Selles WD, Wazer DE, Mason WP, Sailor T, Mackie TR. "Fine tuning of linear accelerator accessories for stereotactic radiotherapy." International Journal of Radiation Oncology*Biology*Physics, vol. 28, no. 4, 1994, pp. 1001-8. |
| Graham RA, Atkins MB, Karp DD, Wazer DE, Hackford AW. "Local excision of rectal carcinoma. Early results with combined chemoradiation therapy using 5-fluorouracil and leucovorin." Diseases of the Colon & Rectum, vol. 37, no. 4, 1994, pp. 308-12. |
| Wazer DE, Chu Q, Liu XL, Gao Q, Safaii H, Band V. "Loss of p53 protein during radiation transformation of primary human mammary epithelial cells." Molecular and Cellular Biology, vol. 14, no. 4, 1994, pp. 2468-78. |
| Wazer DE. "The role of radiation in breast conserving therapy." Obstetrics and gynecology clinics of North America, vol. 21, no. 4, 1994, pp. 681-91. |
| Liu XL, Band H, Gao Q, Wazer DE, Chu Q, Band V. "Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression." Carcinogenesis, vol. 15, no. 9, 1994, pp. 1969-73. |
| Wazer DE, Joyce M, Jung L, Band V. "Alterations in growth phenotype and radiosensitivity after fractionated irradiation of breast carcinoma cells from a single patient." International Journal of Radiation Oncology*Biology*Physics, vol. 26, no. 1, 1993, pp. 81-8. |
| Schmidt-Ullrich RK, Wazer DE, DiPetrillo T, Marchant DJ, Smith TJ, Safaii H, Schmid C, Homer MJ. "Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates: a case for aggressive therapy to the tumor bearing quadrant." International Journal of Radiation Oncology*Biology*Physics, vol. 27, no. 3, 1993, pp. 545-52. |
| Oates E, Touliopoulos P, Wazer DE. "Demonstration of unilateral sialadenitis on postradiotherapy gallium-67-citrate imaging." Journal of Nuclear Medicine, vol. 34, no. 6, 1993, pp. 953-4. |
| Hillyer CD, Hall JM, Lackey DA, Wazer DE. "Development of a colorimetric dosimeter for quality control of blood units and irradiators." Transfusion, vol. 33, no. 11, 1993, pp. 898-901. |
| Hauser SH, Calorini L, Wazer DE, Gattoni-Celli S. "Radiation-enhanced expression of major histocompatibility complex class I antigen H-2Db in B16 melanoma cells." Cancer Research, vol. 53, no. 8, 1993, pp. 1952-5. |
| Tercilla OF, Schmidt-Ullrich R, Wazer DE. "Reirradiation of head and neck neoplasms using twice-a-day scheduling." Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], vol. 169, no. 5, 1993, pp. 285-90. |
| Saris SC, Solares GR, Wazer DE, Cano G, Kerley SE, Joyce MA, Adelman LS, Harling OK, Madoc-Jones H, Zamenhof RG. "Boron neutron capture therapy for murine malignant gliomas." Cancer Research, vol. 52, no. 17, 1992, pp. 4672-7. |
| Johnson CR, Schmidt-Ullrich RK, Wazer DE. "Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck." Cancer, vol. 69, no. 11, 1992, pp. 2749-54. |
| Schmidt-Ullrich RK, Valerie K, Chan W, Wazer DE, Lin PS. "Expression of oestrogen receptor and transforming growth factor-alpha in MCF-7 cells after exposure to fractionated irradiation." International journal of radiation biology, vol. 61, no. 3, 1992, pp. 405-15. |
| Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ, Robert NJ. "Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma." Journal of Clinical Oncology, vol. 10, no. 3, 1992, pp. 356-63. |
| Smith TJ, Wazer DE, Robert NJ, Homer MJ, Safaii H. "Local/regional therapy of primary breast cancer: a contemporary multimodal approach." Seminars in oncology, vol. 19, no. 3, 1992, pp. 230-8. |
| Schmidt-Ullrich RK, Johnson CR, Wazer DE, Masko G, Chasin WD, Karmody CS. "Accelerated superfractionated irradiation for advanced carcinoma of the head and neck: concomitant boost technique." International Journal of Radiation Oncology*Biology*Physics, vol. 21, no. 3, 1991, pp. 563-8. |
| Wazer DE, Joyce M, Solares G, Schmidt-Ullrich R. "Proliferative inhibition of human breast carcinoma cells by high concentration estradiol does not alter radiosensitivity." Breast cancer research and treatment, vol. 18, no. 3, 1991, pp. 141-8. |
| Hillyer CD, Comenzo RL, Miller KB, Schenkein DP, Tiegerman KO, Fogaren TA, Wazer DE, Parker L, Abrams RA, Desforges JF. "Prompt engraftment using autologous peripheral blood stem cells for double autologous bone marrow rescue." American Journal of Hematology, vol. 36, no. 2, 1991, pp. 152-3. |
| Krosnick SH, Wazer DE. "A linear quadratic analysis of differing fractionation schemes for prophylactic cranial irradiation." Journal of Clinical Oncology, vol. 8, no. 9, 1990, pp. 1599-600. |
| Madoc-Jones H, Wazer DE, Zamenhof RG, Harling OK, Bernard JA Jr. "Clinical considerations for neutron capture therapy of brain tumors." Basic life sciences, vol. 54, 1990, pp. 23-35. |
| Zamenhof RG, Clement SD, Harling OK, Brenner JF, Wazer DE, Madoc-Jones H, Yanch JC. "Monte Carlo based dosimetry and treatment planning for neutron capture therapy of brain tumors." Basic life sciences, vol. 54, 1990, pp. 283-305. |
| Wazer DE, Schmidt-Ullrich R, Chasin W, Wu A, Buscher M. "High-dose boost irradiation techniques for carcinoma of the nasopharynx." American journal of otolaryngology, vol. 10, no. 3, 1989, pp. 173-80. |
| Robert NJ, Wazer DE, Smith TJ, Homer MJ, Safaii H, Marchant DJ. "In situ breast cancer: a multidisciplinary approach." Hospital practice (Office ed.), vol. 24, no. 4, 1989, pp. 169-76, 179-85. |
| Wazer DE, Tercilla OF, Lin PS, Schmidt-Ullrich R. "Modulation in the radiosensitivity of MCF-7 human breast carcinoma cells by 17B-estradiol and tamoxifen." The British Journal of Radiology, vol. 62, no. 744, 1989, pp. 1079-83. |
| Wazer DE, Schmidt-Ullrich R, Keisch M, Karmody CS, Koch W. "The role of combined composite resection and irradiation in the management of carcinoma of the oral cavity and oropharynx." Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], vol. 165, no. 1, 1989, pp. 18-22. |
| Schmidt-Ullrich R, Wazer DE, Tercilla O, Safaii H, Marchant DJ, Smith TJ, Homer MA, Robert NJ. "Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma." International Journal of Radiation Oncology*Biology*Physics, vol. 17, no. 4, 1989, pp. 733-8. |
| Wazer DE, Willett BL. "Clinical considerations in palliative treatment of metastatic prostate carcinoma." International Journal of Radiation Oncology*Biology*Physics, vol. 13, no. 1, 1987, pp. 145-6. |
| Wazer DE, Rotrosen J. "Murine lymphocytes lack clearly defined receptors for muscarinic and dopaminergic ligands." The Journal of pharmacy and pharmacology, vol. 36, no. 12, 1984, pp. 853-4. |
| Stanley M, Wazer D. "High plasma concentrations of metoclopramide are not detected by radioreceptor assay." Neuropsychobiology, vol. 10, no. 2-3, 1983, pp. 108-10. |
| Stanley M, Wazer D, Virgilio J, Kuhn CM, Benson DI, Meyerson LR. "Lack of potency of metoclopramide's metabolites in various dopaminergic models." Pharmacology Biochemistry and Behavior, vol. 18, no. 2, 1983, pp. 263-6. |
| Wazer DE, Mandio Cordasco D, Segarnick DJ, Lippa AS, Meyerson LR, Benson D, Rotrosen J. "Norepinephrine stimulation of phospholipid methylation in rat cortical synaptosomes: fact or artifact?." Life sciences, vol. 32, no. 22, 1983, pp. 2535-44. |
| Wazer DE, Rotrosen J, Stanley M. "The benzamides: evidence for action at dopamine receptors--shortcomings of current models." Advances in biochemical psychopharmacology, vol. 35, 1982, pp. 83-95. |
| Rotrosen J, Stanley M, Lautin A, Wazer D, Gershon S. "Discrimination of functionally heterogeneous receptor subpopulations: antipsychotic and antidopaminergic properties of metoclopramide [proceedings]." Psychopharmacology bulletin, vol. 17, no. 1, 1981, pp. 110-3. |
| Lautin A, Wazer D, Stanley M, Rotorsen J, Gershon S. "Chronic treatment with metoclopramide induces behavioral supersensitivity to apomorphine and enhances specific binding of 3H-spiroperidol to rat striata." Life sciences, vol. 27, no. 4, 1980, pp. 305-16. |
| Rotrosen J, Stanley M, Kuhn C, Wazer D, Gershon S. "Experimental dystonia induced by quaternary-chlorpromazine." Neurology, vol. 30, no. 8, 1980, pp. 878-81. |
| Stanley M, Rotrosen J, Lautin A, Wazer D, Gershon S. "Tardive dyskinesia and metoclopramide." The Lancet, vol. 2, no. 8153, 1979, pp. 1190. |
| Year | Degree | Institution |
|---|---|---|
| 1982 | MD | New York University |
| 1978 | AB | College of the Holy Cross |
| Chief Resident | Tufts University School of Medicine, New England Medical Center, radiation oncology | 1987-1988 | Boston, MA |
| Resident | Tufts University School of Medicine, New England Medical Center, radiation oncology | 1985-1987 | Boston, MA |
| Research Fellow | New York University School of Medicine, neurochemistry | 1983-1984 | New York, NY |
| Intern | Brown University, Roger Williams General Hospital, medicine | 1982-1983 | Providence, RI |
| Medical License | Rhode Island | 1998-Present | #9674 |
| Certification | American Board of Radiology, Therapeutic radiology | 1988- | |
| Medical License | Massachusetts | 1985-Present | #59408 |
| Medical License | New York | 1983-1985 |
| Medical Director. Radiosurgery Center of Rhode Island, 2008-Present |
| Radiation Oncologist-in-Chief. Tufts Medical Center, 2008-Present |
| Consultant. Saints Memorial Medical Center, 2000-2007 |
| Radiation Oncologist-in-Chief. Women & Infants Hospital of Rhode Island, 1999-Present |
| Consultant. The Miriam Hospital, 1998-Present |
| Radiation Oncologist-in-Chief. Rhode Island Hospital, 1998-Present |
| Radiation Oncologist-in-Chief. New England Medical Center, 1996-2008 |
| Consultant. Newton-Wellesley Hospital, 1995-2001 |
| Consultant. Carney Hospital, 1995-2002 |
| Consultant. Milton Hospital, 1995-2001 |
| Associate Radiotherapist-in-Chief. New England Medical Center, 1993-1996 |
| Consultant. Whidden Memorial Hospital, 1990-1992 |
| Radiotherapist. New England Medical Center, 1990-1993 |
| Clinical Director. New England Medical Center, 1990-1996 |
| Assistant Radiotherapist. New England Medical Center, 1988-1990 |
